USPTO serial 79417416
PANAROMIC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 17, 2026
- Examiner
- RUTLAND, BARBARA A
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PANAROMIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alex P. Garens
Alex P. Garens Day Pitney LLPOne Federal Street, 29th FloorBoston, MA 02110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific apparatus and instruments for analysing biofluids and detecting diseases; laboratory apparatus and instruments for microscopy, namely, microscopes; scientific apparatus, namely, spectrometers and parts and fittings therefor; spectroscopes; scientific apparatus, namely, spectrophotometers for measuring the infrared spectrum of biofluids for the purpose of detecting diseases; mass spectrometry apparatus; spectrograph apparatus; data processing equipment, namely, couplers; downloadable computer software for use in medical and clinical analysis and disease diagnostics for analyzing medical data to assist in providing clinical interpretations; computer hardware; downloadable electronic publications in the nature of newsletters, reports and brochures in the field of science and medicine; data processing apparatus with artificial intelligence; downloadable artificial intelligence and machine learning software for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; research laboratory analysers for measuring, testing and analysing blood and other bodily fluids | ACTIVE | — |
| 010 | Medical apparatus and instruments for analysing biofluids and detecting diseases; diagnostic apparatus for medical purposes, namely, analysing biofluids and detecting diseases; medical apparatus for the treatment of cancer; blood testing apparatus; medical diagnostic instruments and apparatus for the analysis of bodily fluids; medical apparatus, instruments and devices for liquid biopsy analysis; parts and fittings for all the aforesaid goods | ACTIVE | — |
| 042 | Scientific and technological services, namely, research, design, scientific analysis and scientific testing in the field of medical and clinical analysis and disease diagnostics; industrial analysis and research services in the field of medical and clinical analysis and disease diagnostics; design and development of computer hardware and software; design and development of computer software for use with medical technology; engineering services and design services for scientific equipment and apparatus for microscopy, spectroscopy and scientific imaging; medical research services; clinical research in the field of biofluid analysis and disease detection; medical laboratory services; computer programming in the medical field; design and development of medical technology; design and development of medical diagnostic apparatus; blood analysis services; scientific research for medical purposes in the area of cancerous diseases; research in the field of artificial intelligence; providing on-line non-downloadable software using artificial intelligence for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; software as a service (SaaS) services featuring software using artificial intelligence for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; software as a service (SaaS) services featuring software for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; scientific and technological services, namely, scientific analysis and evaluation of scientific and medical data, in connection with providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; scientific and technological services, namely, computerized scientific analysis of technical data in the field of medical and clinical analysis and disease diagnostics; scientific and technological services, namely, conducting of scientific experiments and tests in the field of medical and clinical analysis and disease diagnostics; scientific, medical, and technological research services, namely, analysis of scientific data and technical data in the field of medical and clinical analysis and disease diagnostics; design of scientific experiments; provision of scientific reports relating to scientific research in the field of medical and clinical analysis and disease diagnostics, namely, scientific research consulting; advice, information and consultancy services for all of the aforesaid services | ACTIVE | — |
| 044 | Medical services; medical care services; health clinic services; healthcare services, namely, medical analysis services for diagnostic and treatment purposes; medical testing and analysis services for diagnostic purposes, and preparation of reports relating thereto; providing cancer screening services; providing medical information to medical professionals and patients in the form of medical reports relating to health care matters in the field of biofluid analysis and the detection of diseases; medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for the diagnosis of cancer; medical testing of blood; medical testing for diagnostic and treatment purposes in the nature of liquid biopsy testing; advice, information and consultancy services for all of the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DXCOVER LIMITED
- Other trademarks owned by DXCOVER LIMITED
- Other trademarks owned by DXCOVER LIMITED
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PANAROMIC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 28, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 28, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 6, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 20, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 19, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 17, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 17, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 17, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 27, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 27, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 21, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 31, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 30, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 30, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 30, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 20, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 22, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 22, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 22, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 22, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 22, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 15, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 28, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 28, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 1, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 30, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 14, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 14, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 13, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Feb 20, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |